Navigation Links
PharmAthene Receives FDA Clearance to Reinitiate Clinical Testing of Valortim®
Date:12/9/2010

n of the Company's product candidates, unexpected funding delays and/or reductions or elimination of U.S. government funding for one or more of the Company's development programs, the award of government contracts to our competitors, unforeseen safety issues, challenges related to the development, scale-up, technology transfer, and/or process validation of manufacturing processes for our product candidates, unexpected determinations that these product candidates prove not to be effective and/or capable of being marketed as products, challenges related to the implementation of our NYSE Amex compliance plan, as well as risks detailed from time to time in PharmAthene's Forms 10-K and 10-Q under the caption "Risk Factors" and in its other reports filed with the U.S. Securities and Exchange Commission (the "SEC").  In particular, at this point there can be no assurance that Valortim® will be shown to be safe and effective and approved by regulatory authorities for use in humans.  

Copies of PharmAthene's public disclosure filings are available from its investor relations department and our website under the investor relations tab at www.PharmAthene.com.


'/>"/>
SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. PharmAthene Reports Third Quarter 2010 Financial and Operational Results
2. PharmAthene Receives Four Therapeutic Discovery Project Grants Totaling Approximately $850,000
3. PharmAthene Announces Pricing of $15 Million Public Offering
4. PharmAthene Announces Proposed Common Stock Offering
5. PharmAthene Announces $3.9 Million Registered Direct Offering
6. PharmAthene CEO To Participate on Biosecurity Panel at the 2010 BIO International Conference
7. PharmAthene Appoints Mitchel Sayare, Ph.D. to the Companys Board of Directors
8. PharmAthene Reports Year-End 2009 Financial and Operational Results and Provides Update On Ongoing Litigation With SIGA Technologies
9. PharmAthene to Provide Update on SparVax(TM) Contract Modification Suspension During Year-End 2009 Financial and Operational Results Conference Call on Tuesday March 23, 2010
10. PharmAthene to Host Year-End 2009 Earnings Conference Call and Webcast on Tuesday, March 23, 2010
11. PharmAthene to Present at the 2010 Roth Capital Markets Growth Stock Conference on Monday, March 15, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... Sunnyvale, CA (PRWEB) July 29, 2014 ... for medical devices, and cloud based eClinical technologies, have ... Med Device Online. These follow a long line of ... high profile publications including Life Science Leader, Pharmaceutical Online, ... Basics Clinovo provided a paper by CTO Marc Desgrousilliers, ...
(Date:7/28/2014)... The Workgroup for Electronic Data Interchange ... of health IT to create efficiencies in healthcare information ... Workgroup has developed an issue brief titled, “What ... The HPID Workgroup, a part of WEDI’s Strategic National ... Medicare and Medicaid Services (CMS) to identify common misuse ...
(Date:7/28/2014)... , July 28, 2014 /PRNewswire/ -   JOLT ... group of companies to join its growing portfolio of ... of Toronto,s JOLT accelerator, and ... on the roster. Since its launch ... have successfully raised  $7.5M of financing. Now at 23 ...
(Date:7/28/2014)... St Louis, MO (PRWEB) July 28, 2014 ... tools, software, and services that bring the power of ... for the inaugural Appistry Pipeline Challenge . ... Callum Bell, president of the National Center for Genome ... Children’s Mercy Hospitals and Clinics of Kansas City. Rounding ...
Breaking Biology Technology:Clinovo White Papers Published in Summer 2014 Editions of Leading Medical Device & Pharmaceutical Publications 2Clinovo White Papers Published in Summer 2014 Editions of Leading Medical Device & Pharmaceutical Publications 3WEDI’s HPID Workgroup Announces Release of Issue Brief: “What is the Difference Between a Health Plan and Payer?” 2JOLT Announces the Next 6 Startups to Join its Summer 2014 Cohort 2JOLT Announces the Next 6 Startups to Join its Summer 2014 Cohort 3Appistry Names Industry Experts from the National Center for Genome Resources and Mercy Children's, Kansas City, to Judge Pipeline Challenge Competition 2
... Md., June 12 /Xinhua-PRNewswire/ -- Chindex International,Inc. (Nasdaq: ... international,healthcare services and Western healthcare products in the ... to charges in,the fourth quarter which will be ... which will be filed with the Securities and ...
... Supports Development of Strong Scientific Capacity in Latin,America, ... and the University of California at San Francisco ... been named 2008 Pew,Latin American Fellows in the ... UCSF, the highly competitive fellowship program offers talented,young ...
... The new Pearl(TM) In Vivo,Imaging System for ... (NIR) results in less than 30 seconds. The ... Infrared Dyes, the proven performers,for NIR imaging at ... are acquired in 30 seconds," says,Jeff Harford, LI-COR ...
Cached Biology Technology:Chindex International, Inc. Quantifies Fourth Quarter Charges 2Chindex International, Inc. Quantifies Fourth Quarter Charges 3Ten Latin American Scientists Named 2008 Pew Fellows in the Biomedical Sciences 2LI-COR Biosciences Introduces Near-Infrared Small Animal Imager 2
(Date:7/28/2014)... the United States have a circulatory problem of the ... and may even require surgery in serious cases. This ... in turn, limb amputation. , At The University of ... scientists tested a non-surgical preventative treatment in a mouse ... increased blood circulation. Their proof-of-concept study appears in ...
(Date:7/28/2014)... pennellii , a wild relative of the domestic tomato, ... including the labs headed by Professors Neelima Sinha and ... Biology. The new genome information may help breeders produce ... 27 in the journal Nature Genetics , was ... in Germany. The UC Davis labs carried out work ...
(Date:7/28/2014)... himself the bug hunter, but the target of his ... and identified with special methods and instruments. Benjamin Hause, ... Diagnostic Laboratory at Kansas State University, recently published an ... which is an important find in the United States. ... didn,t know what it was," Hause said. "We used ...
Breaking Biology News(10 mins):Scientists discover genetic switch that can prevent peripheral vascular disease in mice 2Researcher using next-generation sequencing to rapidly identify pathogens 2Researcher using next-generation sequencing to rapidly identify pathogens 3
... human DNA is the genetic equivalent of e-mail spam: short ... more of themselves. After starting out in our primate ... called an Alu retrotransposon now takes up 10 percent of ... newborn baby has a new Alu retrotransposon somewhere in its ...
... of how neurons and muscle cells establish lifelong communication ... may be mutated and/or attacked in muscular dystrophy. ... direct construction of the nerve-muscle contact or synapse. MuSK ... talk so synpases can form and receptors that enable ...
... are exposed to a wide range of environmental threats ... life, throughout their youth and into adulthood. Writing in ... Environmental Health scientists from the World Health Organization ... both industrialized and developing countries to assess the environmental ...
Cached Biology News:Mapping a clan of mobile selfish genes 2Mapping a clan of mobile selfish genes 3Mediator in communication between neurons and muscle cells found 2Childhood environmental health 2
... materials necessary for the isolation and preparation of ... Kit Components: Erythrocyte ... containing 220 mL of buffered ammonium chloride. (NH ... No. 5113) One bottle containing 220 mL of ...
nuclear cap binding protein subunit 1, 80kDa, mRNA...
Protein Phosphorylation...
MOUSE ANTI S. NEWPORT SALMONELLA HADAR...
Biology Products: